Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial
Discussion
If this study demonstrates positive findings in support of the superiority of kava over placebo in the treatment of GAD, and also is shown to be safe, then this plant-medicine can be considered a ’first-line‘ therapy for GAD. Genomic and neuroimaging data may reveal clinical response patterns and provide more evidence of the neurobiological activity of the plant extract.
Trial Registration Information
ClinicalTrials.gov: NCT02219880 Date: 13 August 2014: (Source: Trials)
Source: Trials - November 2, 2015 Category: Research Source Type: clinical trials
Investigation of Kava Effects on NNK Metabolism
Condition: Tobacco SmokingIntervention: Dietary Supplement: KavaSponsor: Masonic Cancer Center, University of MinnesotaNot yet recruiting - verified July 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2015 Category: Research Source Type: clinical trials
